Skip to content
Screener

Indivior Pharmaceuticals, Inc. INDV Q2 2026 earnings

Reported August 3, 2026 · Before market open

Revenue$343.0MBeat by $36.8M
EPS$1.15Beat by $0.28
Revenue estimate$306.2M
EPS estimate$0.87

Next report

Oct 29, 2026 (in a month)
Revenue estimate$329.4M
EPS estimate$1.06

Valuation & ratios

Valuation

as of 09/17/26
See full
Market cap$4.05B+41.5%
Enterprise value$4.39B+61.2%
P/E16.2×-10.4×
P/S3.1×+0.7×

FAQ

When did Indivior Pharmaceuticals, Inc. report Q2 2026 earnings?
Indivior Pharmaceuticals, Inc. (INDV) reported Q2 2026 earnings on August 3, 2026 before market open.
What were Indivior Pharmaceuticals, Inc.'s Q2 2026 revenue and EPS?
Indivior Pharmaceuticals, Inc. reported revenue of $343.0M and eps of $1.15 for Q2 2026.
Did Indivior Pharmaceuticals, Inc. beat estimates in Q2 2026?
Revenue beat the consensus estimate of $306.2M by $36.8M. EPS beat the consensus estimate of $0.87 by $0.28.
How did Indivior Pharmaceuticals, Inc.'s Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 13.6% from $302.0M a year earlier and eps grew 125.5% from $0.51.
Where can I find Indivior Pharmaceuticals, Inc.'s Q2 2026 SEC filings?
You can read the 8-K earnings release (0001193125-26-329513) and the 10-Q periodic report (0001628280-26-051895) directly on SEC EDGAR. The filing index links above go to sec.gov.